$NASDAQ:GH

Guardant Health Raises $90.7 Million in Registered Direct Offering with Baillie Gifford
Gallery

Guardant Health Raises $90.7 Million in Registered Direct Offering with Baillie Gifford

🌥️Trending News Guardant Health ($NASDAQ:GH), a leading precision oncology company, recently raised $90.7 million in a Registered Direct Offering with [...]

By GoodWhale|December 26, 2023|Categories: Diagnostics & Research|Tags: $NASDAQ:GH, Diagnostics & Research, NASDAQ|0 Comments

Wolfe Research Now Offering Coverage of Guardant Health
Gallery

Wolfe Research Now Offering Coverage of Guardant Health

🌥️Trending News Wolfe Research is thrilled to announce that they are now providing coverage of Guardant Health ($NASDAQ:GH). Guardant Health, [...]

By GoodWhale|December 20, 2023|Categories: Diagnostics & Research|Tags: $NASDAQ:GH, Diagnostics & Research, NASDAQ|0 Comments

FDA Panel to Evaluate Guardant Health Colorectal Test on March 28
Gallery

FDA Panel to Evaluate Guardant Health Colorectal Test on March 28

🌥️Trending News On March 28th, a panel from the Food and Drug Administration (FDA) will be evaluating Guardant Health ($NASDAQ:GH)'s [...]

By GoodWhale|December 20, 2023|Categories: Diagnostics & Research|Tags: $NASDAQ:GH, Diagnostics & Research, NASDAQ|0 Comments

GUARDANT HEALTH Reports 21.8% Year-Over-Year Revenue Increase in Q3 of FY2023, Net Income Decreases -162.0 Million
Gallery

GUARDANT HEALTH Reports 21.8% Year-Over-Year Revenue Increase in Q3 of FY2023, Net Income Decreases -162.0 Million

☀️Earnings Overview For the third quarter of FY2023 ending September 30 2023, GUARDANT HEALTH ($NASDAQ:GH) reported total revenue of USD [...]

By GoodWhale|December 18, 2023|Categories: Diagnostics & Research, Earnings Report, Profitability|Tags: $NASDAQ:GH, Diagnostics & Research, NASDAQ|0 Comments

Guardant Health Set to Reveal Q2 Earnings: Evaluating Performance and Future Potential
Gallery

Guardant Health Set to Reveal Q2 Earnings: Evaluating Performance and Future Potential

🌥️Introduction: Guardant Health, a pioneering precision oncology company, is gearing up to announce its second-quarter earnings on August 3, 2023, [...]

By GoodWhale|October 21, 2023|Categories: Diagnostics & Research, Earnings Preview, Earnings Report|Tags: $NASDAQ:GH, Diagnostics & Research, NASDAQ|0 Comments

GUARDANT HEALTH Reports 25.7% Increase in Total Revenue for Q2 FY2023 at $137.2 Million
Gallery

GUARDANT HEALTH Reports 25.7% Increase in Total Revenue for Q2 FY2023 at $137.2 Million

☀️Earnings Overview GUARDANT HEALTH ($NASDAQ:GH) reported total revenue of USD 137.2 million for the second quarter of FY2023, a 25.7% [...]

By GoodWhale|August 21, 2023|Categories: Diagnostics & Research, Earnings Report, Profitability|Tags: $NASDAQ:GH, Diagnostics & Research, NASDAQ|0 Comments

Guardant Health Reports Record Second Quarter Earnings for FY2023
Gallery

Guardant Health Reports Record Second Quarter Earnings for FY2023

🌥️Earnings Overview On August 3 2023, GUARDANT HEALTH ($NASDAQ:GH) released their earnings report for the second quarter of FY2023, ending [...]

By GoodWhale|August 10, 2023|Categories: Diagnostics & Research, Earnings Report|Tags: $NASDAQ:GH, Diagnostics & Research, NASDAQ|0 Comments

Guardant Health Stock Jumps 0.86% on Tuesday, June 06
Gallery

Guardant Health Stock Jumps 0.86% on Tuesday, June 06

🌥️Trending News Guardant Health ($NASDAQ:GH) Inc. is an innovative healthcare firm, providing comprehensive genomic analysis for early cancer detection and [...]

By GoodWhale|June 25, 2023|Categories: Diagnostics & Research|Tags: $NASDAQ:GH, Diagnostics & Research, NASDAQ|0 Comments

Medicare Now Covers Guardant Health’s Cancer Immunotherapy Response Test
Gallery

Medicare Now Covers Guardant Health’s Cancer Immunotherapy Response Test

Trending News 🌧️ Guardant Health ($NASDAQ:GH), Inc., a leading precision oncology company, recently announced that Medicare has approved coverage for [...]